Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Zheng, Yang ^a   Yin, Xia ^a,b   Zhai, Xujie ^c   Zhao, Xin ^a   Cai, Lu ^a,b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

^c JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; ANIMAL; ENZYMOLOGY; HEART INFARCTION; HEART INFARCTION PREVENTION; METABOLISM; MORTALITY; MOUSE; PATHOPHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; STATISTICS;

ANIMALS; DIABETES COMPLICATIONS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION;

EID: 80053531754     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/198048     Document Type: Review

References (92)

1. Yellon D. M., Hausenloy D. J., Myocardial reperfusion injury The New England Journal of Medicine 2007 357 11 1074 1135
2. Zhao Z. Q., Corvera J. S., Halkos M. E., Kerendi F., Wang N. P., Guyton R. A., Vinten-Johansen J., Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning American Journal of Physiology 2003 285 2 H579 H588
3. Matsumura K., Jeremy R. W., Schaper J., Becker L. C., Progression of myocardial necrosis during reperfusion of ischemic myocardium Circulation 1998 97 8 795 804 (Pubitemid 28135343)
4. Frangogiannis N. G., Smith C. W., Entman M. L., The inflammatory response in myocardial infarction Cardiovascular Research 2002 53 1 31 47 (Pubitemid 34020764)
5. Gao F. F., Hao S. Y., Huang Z. Q., Zhang Y. M., Zhou Y. Q., Chen Y. C., Liu X. P., Shi G. G., Cardiac electrophysiological and antiarrhythmic effects of N-n-butyl haloperidol iodide Cellular Physiology and Biochemistry 2010 25 4-5 433 442
6. Moens A. L., Claeys M. J., Timmermans J. P., Vrints C. J., Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process International Journal of Cardiology 2005 100 2 179 190
7. Jordan J. E., Zhao Z. Q., Vinten-Johansen J., The role of neutrophils in myocardial ischemia-reperfusion injury Cardiovascular Research 1999 43 4 860 878 (Pubitemid 29413185)
8. Sambandam N., Lopaschuk G. D., AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart Progress in Lipid Research 2003 42 3 238 256 (Pubitemid 36411693)
9. Park J. L., Lucchesi B. R., Mechanisms of myocardial reperfusion injury Annals of Thoracic Surgery 1999 68 5 1905 1912
10. Rosano G. M. C., Fini M., Caminiti G., Barbaro G., Cardiac metabolism in myocardial ischemia Current Pharmaceutical Design 2008 14 25 2551 2562
11. Ding J. W., Tong X. H., Yang J., Liu Z. Q., Zhang Y., Yang J., Li S., Li L., Activated protein C protects myocardium via activation of anti-apoptotic pathways of survival in ischemia-reperfused rat heart Journal of Korean Medical Science 2010 25 11 1609 1615
12. Murry C. E., Jennings R. B., Reimer K. A., Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 1986 74 5 1124 1136 (Pubitemid 17174962)
13. Ferdinandy P., Schulz R., Baxter G. F., Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning Pharmacological Reviews 2007 59 4 418 458
14. Gross E. R., Hsu A. K., Gross G. J., The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 American Journal of Physiology 2006 291 2 H827 H834
15. Tsang A., Hausenloy D. J., Mocanu M. M., Carr R. D., Yellon D. M., Preconditioning the diabetic heart: the importance of Akt phosphorylation Diabetes 2005 54 8 2360 2364 (Pubitemid 41134263)
16. Hausenloy D. J., Yellon D. M., Survival kinases in ischemic preconditioning and postconditioning Cardiovascular Research 2006 70 2 240 253
17. Boengler K., Buechert A., Heinen Y., Roeskes C., Hilfiker-Kleiner D., Heusch G., Schulz R., Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice Circulation Research 2008 102 1 131 135
18. Penumathsa S. V., Thirunavukkarasu M., Samuel S. M., Zhan L., Maulik G., Bagchi M., Bagchi D., Maulik N., Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury Biochimica et Biophysica Acta 2009 1792 1 39 48
19. Gao F., Gao E., Yue T. L., Ohlstein E. H., Lopez B. L., Christopher T. A., Ma X. L., Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation Circulation 2002 105 12 1497 1502 (Pubitemid 34263284)
20. Hausenloy D. J., Yellon D. M., New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovascular Research 2004 61 3 448 460 (Pubitemid 38210151)
21. Juhaszova M., Zorov D. B., Kim S. H., Pepe S., Fu Q., Fishbein K. W., Ziman B. D., Wang S., Ytrehus K., Antos C. L., Olson E. N., Sollott S. J., Glycogen synthase kinase-3 mediates convergence of protection signalling to inhibit the mitochondrial permeability transition pore Journal of Clinical Investigation 2004 113 11 1535 1549 (Pubitemid 39071677)
22. Tong H., Imahashi K., Steenbergen C., Murphy E., Phosphorylation of glycogen synthase kinase-3 during preconditioning through a phosphatidylinositol-3-kinasedependent pathway is cardioprotective Circulation Research 2002 90 4 377 379 (Pubitemid 34633905)
23. Miura T., Miki T., GSK-3, a therapeutic target for cardiomyocyte protection Circulation Journal 2009 73 7 1184 1192
24. Juhaszova M., Zorov D. B., Yaniv Y., Nuss H. B., Wang S., Sollott S. J., Role of glycogen synthase kinase-3 in cardioprotection Circulation Research 2009 104 11 1240 1252
25. Yang X., Cohen M. V., Downey J. M., Mechanism of cardioprotection by early ischemic preconditioning Cardiovascular Drugs and Therapy 2010 24 3 225 234
26. Miura T., Miki T., Yano T., Role of the gap junction in ischemic preconditioning in the heart American Journal of Physiology 2010 298 4 H1115 H1125
27. Penna C., Mancardi D., Rastaldo R., Pagliaro P., Cardioprotection: a radical view. Free radicals in pre and postconditioning Biochimica et Biophysica Acta 2009 1787 7 781 793
28. Das M., Das D. K., Molecular mechanism of preconditioning IUBMB Life 2008 60 4 199 203
29. Yellon D. M., Opie L. H., Postconditioning for protection of the infarcting heart The Lancet 2006 367 9509 456 458 (Pubitemid 43208888)
30. Kin H., Zhao Z. Q., Sun H. Y., Wang N. P., Corvera J. S., Halkos M. E., Kerendi F., Guyton R. A., Vinten-Johansen J., Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion Cardiovascular Research 2004 62 1 74 85 (Pubitemid 38326813)
31. Philipp S., Yang X. M., Cui L., Davis A. M., Downey J. M., Cohen M. V., Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade Cardiovascular Research 2006 70 2 308 314
32. Penna C., Cappello S., Mancardi D., Raimondo S., Rastaldo R., Gattullo D., Losano G., Pagliaro P., Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway Basic Research in Cardiology 2006 101 2 168 179 (Pubitemid 43250809)
33. Argaud L., Gateau-Roesch O., Augeul L., Couture-Lepetit E., Loufouat J., Gomez L., Robert D., Ovize M., Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts American Journal of Physiology 2008 294 1 H386 H391
34. Miura T., Miki T., Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy Basic Research in Cardiology 2008 103 6 501 513
35. Gomez L., Paillard M., Thibault H., Derumeaux G., Ovize M., Inhibition of GSK3 by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion Circulation 2008 117 21 2761 2768 (Pubitemid 351770456)
36. Tsang A., Hausenloy D. J., Mocanu M. M., Yellon D. M., Postconditioning: a form of modified reperfusion protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway Circulation Research 2004 95 3 230 232 (Pubitemid 39056282)
37. Javador S. A., Clarke S., Das M., Griffiths E. J., Lim K. H. H., Halestrap A. P., Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart Journal of Physiology 2003 549 2 513 524 (Pubitemid 36701762)
38. Mozaffari M. S., Liu J. Y., Schaffer S. W., Effect of pressure overload on cardioprotection via PI3K-Akt: comparison of postconditioning, insulin, and pressure unloading American Journal of Hypertension 2010 23 6 668 674
39. Bopassa J. C., Ferrera R., Gateau-Roesch O., Couture-Lepetit E., Ovize M., PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning Cardiovascular Research 2006 69 1 178 185 (Pubitemid 41814821)
40. Murphy E., Steenbergen C., Preconditioning: the mitochondrial connection Annual Review of Physiology 2007 69 51 67 (Pubitemid 46457635)
41. Lee S., Chanoit G., McIntosh R., Zvara D. A., Xu Z., Molecular mechanism underlying Akt activation in zinc-induced cardioprotection American Journal of Physiology 2009 297 2 H569 H575
42. Chanoit G., Lee S., Xi J., Zhu M., McIntosh R. A., Mueller R. A., Norfleet E. A., Xu Z., Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3 American Journal of Physiology 2008 295 3 H1227 H1233
43. Ghaboura N., Tamareille S., Ducluzeau P.-H., Grimaud L., Loufrani L., Croué A., Tourmen Y., Henrion D., Furber A., Prunier F., Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3 signaling Basic Research in Cardiology 2011 106 1 147 162
44. Yadav H. N., Singh M., Sharma P. L., Involvement of GSK-3 in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart Molecular and Cellular Biochemistry 2010 343 1-2 75 81
45. Griffiths E. J., Halestrap A. P., Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion Biochemical Journal 1995 307 1 93 98
46. Argaud L., Gateau-Roesch O., Muntean D., Chalabreysse L., Loufouat J., Robert D., Ovize M., Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury Journal of Molecular and Cellular Cardiology 2005 38 2 367 374 (Pubitemid 40215206)
47. Argaud L., Gateau-Roesch O., Raisky O., Loufouat J., Robert D., Ovize M., Postconditioning inhibits mitochondrial permeability transition Circulation 2005 111 2 194 197 (Pubitemid 40139731)
48. Rasola A., Bernardi P., The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis Apoptosis 2007 12 5 815 833 (Pubitemid 46653292)
49. Kowaltowski A. J., Castilho R. F., Grijalba M. T., Bechara E. J. H., Vercesi A. E., Effect of inorganic phosphate concentration on the nature of inner mitochondrial membrane alterations mediated by Ca 2+ ions: a proposed model for phosphate-stimulated lipid peroxidation Journal of Biological Chemistry 1996 271 6 2929 2934
50. Crompton M., Mitochondrial intermembrane junctional complexes and their role in cell death Journal of Physiology 2000 529 1 11 21
51. Nishino Y., Webb I. G., Davidson S. M., Ahmed A. I., Clark J. E., Jacquet S., Shah A. M., Miura T., Yellon D. M., Avkiran M., Marber M. S., Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse Circulation Research 2008 103 3 307 314
52. Donahoe S. M., Stewart G. C., McCabe C. H., Mohanavelu S., Murphy S. A., Cannon C. P., Antman E. M., Diabetes and mortality following acute coronary syndromes Journal of the American Medical Association 2007 298 7 765 775 (Pubitemid 47263159)
53. Boudina S., Abel E. D., Diabetic cardiomyopathy revisited Circulation 2007 115 25 3213 3223 (Pubitemid 47012236)
54. Haffner S. M., Lehto S., Rnnemaa T., Pyrl K., Laakso M., Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction The New England Journal of Medicine 1998 339 4 229 234 (Pubitemid 28350165)
55. Juutilainen A., Lehto S., Rnnemaa T., Pyrl K., Laakso M., Type 2 diabetes as a coronary heart disease equivalent: an 18-year prospective population-based study in Finnish subjects Diabetes Care 2005 28 12 2901 2907 (Pubitemid 43942922)
56. Zuanetti G., Latini R., Maggioni A. P., Santoro L., Franzosi M. G., Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study Journal of the American College of Cardiology 1993 22 7 1788 1794 (Pubitemid 23359632)
57. Herlitz J., Karlson B. W., Lindqvist J., Sjlin M., Rate and mode of death during five years of follow-up among patients with acute chest pain with and without a history of diabetes mellitus Diabetic Medicine 1998 15 4 308 314 (Pubitemid 28168511)
58. Abel E. D., Insulin signaling in heart muscle: lessons from genetically engineered mouse models Current Hypertension Reports 2004 6 6 416 423 (Pubitemid 39600096)
59. Abel E. D., Myocardial insulin resistance and cardiac complications of diabetes Current Drug Targets: Immune, Endocrine and Metabolic Disorders 2005 5 2 219 226 (Pubitemid 40766868)
60. Laviola L., Belsanti G., Davalli A. M., Napoli R., Perrini S., Weir G. C., Giorgino R., Giorgino F., Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart Diabetes 2001 50 12 2709 2720 (Pubitemid 33733121)
61. Ali Raza J., Movahed A., Current concepts of cardiovascular diseases in diabetes mellitus International Journal of Cardiology 2003 89 2-3 123 134 (Pubitemid 36588931)
62. Yu C., Chen Y., Cline G. W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J. K., Cushman S. W., Cooney G. J., Atcheson B., White M. F., Kraegen E. W., Shulman G. I., Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle Journal of Biological Chemistry 2002 277 52 50230 50236 (Pubitemid 36042170)
63. Wang Y., Feng W., Xue W., Tan Y., Hein D. W., Li X. K., Cai L., Inactivation of GSK-3 by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling Diabetes 2009 58 6 1391 1402
64. Wang J., Song Y., Elsherif L., Song Z., Zhou G., Prabhu S. D., Saari J. T., Cai L., Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation Circulation 2006 113 4 544 554
65. Barthel A., Ostrakhovitch E. A., Walter P. L., Kampktter A., Klotz L. O., Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences Archives of Biochemistry and Biophysics 2007 463 2 175 182 (Pubitemid 47030342)
66. Mocanu M. M., Yellon D. M., PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? British Journal of Pharmacology 2007 150 7 833 838 (Pubitemid 46536622)
67. Wu W., Wang X., Zhang W., Reed W., Samet J. M., Whang Y. E., Ghio A. J., Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells Journal of Biological Chemistry 2003 278 30 28258 28263 (Pubitemid 36900027)
68. Peart J. N., Headrick J. P., Adenosinergic cardioprotection: multiple receptors, multiple pathways Pharmacology and Therapeutics 2007 114 2 208 221 (Pubitemid 46561536)
69. You L., Li L., Xu Q., Ren J., Zhang F., Postconditioning reduces infarct size and cardiac myocyte apoptosis via the opioid receptor and JAK-STAT signaling pathway Molecular Biology Reports 2010 1 7
70. Zatta A. J., Kin H., Yoshishige D., Jiang R., Wang N., Reeves J. G., Mykytenko J., Guyton R. A., Zhao Z. Q., Caffrey J. L., Vinten-Johansen J., Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation American Journal of Physiology 2008 294 3 H1444 H1451
71. Gross E. R., Hsu A. K., Gross G. J., Opioid-induced cardioprotection occurs via glycogen synthase kinase inhibition during reperfusion in intact rat hearts Circulation Research 2004 94 7 960 966 (Pubitemid 38490074)
72. Nishihara M., Miura T., Miki T., Sakamoto J., Tanno M., Kobayashi H., Ikeda Y., Ohori K., Takahashi A., Shimamoto K., Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 American Journal of Physiology 2006 291 2 H748 H755
73. Namiuchi S., Kagaya Y., Ohta J., Shiba N., Sugi M., Oikawa M., Kunii H., Yamao H., Komatsu N., Yui M., Tada H., Sakuma M., Watanabe J., Ichihara T., Shirato K., High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention Journal of the American College of Cardiology 2005 45 9 1406 1412 (Pubitemid 40615610)
74. Bullard A. J., Govewalla P., Yellon D. M., Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo Basic Research in Cardiology 2005 100 5 397 403 (Pubitemid 41300494)
75. Fang N. X., Yao Y. T., Shi C. X., Li L. H., Attenuation of ischemia-reperfusion injury by sevoflurane postconditioning involves protein kinase B and glycogen synthase kinase 3 beta activation in isolated rat hearts Molecular Biology Reports 2010 37 8 3763 3769
76. Tosaki A., Engelman D. T., Engelman R. M., Das D. K., The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts Cardiovascular Research 1996 31 4 526 536 (Pubitemid 26140063)
77. Gross E. R., Hsu A. K., Gross G. J., Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3 Diabetes 2007 56 1 127 136
78. Hotta H., Miura T., Miki T., Togashi N., Maeda T., Kim S. J., Tanno M., Yano T., Kuno A., Itoh T., Satoh T., Terashima Y., Ishikawa S., Shimamoto K., Short communication: angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts Circulation Research 2010 106 1 129 132
79. Shi-Ting W., Mang-Hua X., Wen-Ting C., Feng-Hou G., Zhu-Ying G., Study on tolerance to ischemia-reperfusion injury and protection of ischemic preconditioning of type1 diabetes rat heart. Biomedicine and Pharmacotherapy. In press
80. Przyklenk K., Maynard M., Greiner D. L., Whittaker P., Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes Antioxidants and Redox Signaling 2011 14 5 781 790
81. Drenger B., Ostrovsky I. A., Barak M., Nechemia-Arbely Y., Ziv E., Axelrod J. H., Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition Anesthesiology 2011 114 6 1364 1372
82. Zhuo C., Wang Y., Wang X., Wang Y., Chen Y., Cardioprotection by ischemic postconditioning is abolished in depressed rats: role of Akt and signal transducer and activator of transcription-3 Molecular and Cellular Biochemistry 2011 346 1-2 39 47
83. Huhn R., Heinen A., Weber N. C., Hollmann M. W., Schlack W., Preckel B., Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore British Journal of Anaesthesia 2008 100 4 465 471 (Pubitemid 351773615)
84. Balaraman Y., Limaye A. R., Levey A. I., Srinivasan S., Glycogen synthase kinase 3 and Alzheimer's disease: pathophysiological and therapeutic significance Cellular and Molecular Life Sciences 2006 63 11 1226 1235 (Pubitemid 43939009)
85. Raphael J., Gozal Y., Navot N., Zuo Z., Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling Journal of Cardiovascular Pharmacology 2010 55 4 348 357
86. Kupai K., Csonka C., Fekete V., Odendaal L., Van Rooyen J., Marais D. W., Csont T., Ferdinandy P., Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite American Journal of Physiology 2009 297 5 H1729 H1735
87. Su H., Sun X., Ma H., Zhang H.-F., Yu Q.-J., Huang C., Wang X.-M., Luan R.-H., Jia G.-L., Wang H.-C., Gao F., Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK American Journal of Physiology 2007 293 3 E629 E635
88. Ilouz R., Kaidanovich O., Gurwitz D., Eldar-Finkelman H., Inhibition of glycogen synthase kinase-3 by bivalent zinc ions: insight into the insulin-mimetic action of zinc Biochemical and Biophysical Research Communications 2002 295 1 102 106 (Pubitemid 34743782)
89. Viswanath K., Bodiga S., Balogun V., Zhang A., Bodiga V. L., Cardioprotective effect of zinc requires ErbB2 and Akt during hypoxia/reoxygenation BioMetals 2010 24 1 171 180
90. Penna C., Mancardi D., Rastaldo R., Losano G., Pagliaro P., Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling Cardiovascular Research 2007 75 1 168 177 (Pubitemid 46881061)
91. Parsa C. J., Matsumoto A., Kim J., Riel R. U., Pascal L. S., Walton G. B., Thompson R. B., Petrofski J. A., Annex B. H., Stamler J. S., Koch W. J., A novel protective effect of erythropoietin in the infarcted heart Journal of Clinical Investigation 2003 112 7 999 1007 (Pubitemid 38056315)
92. Lamont K. T., Somers S., Lacerda L., Opie L. H., Lecour S., Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection Journal of Pineal Research 2011 50 4 374 380